Clinical Trial Update: 18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis

View source ↗

Summary

A clinical trial evaluating an 18F-labeled FAP-targeted molecular imaging probe for early tumor diagnosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Neuroendocrine Tumor
• Pancreatic Cancer
• Thyroid Cancer

Drugs mentioned

• 18F-labeled FAP-targeted molecular probe (Fluorine-18 labeled fibroblast activation protein (FAP) targeted molecular imaging probe)

Snippet

Sponsor: Nanjing First Hospital, Nanjing Medical University | Conditions: Lung Cancers, Pancreatic Cancer | Status: RECRUITING